Perimeter Medical Imaging AI Announces C$13.5M Private Placement for Cancer Detection Technology

Curated by THEOUTPOST

On Tue, 10 Sept, 4:03 PM UTC

2 Sources

Share

Perimeter Medical Imaging AI, a medical technology company, is seeking to raise C$13.5 million through a non-brokered private placement to support its AI-powered cancer detection technology.

Funding Initiative Announced

Perimeter Medical Imaging AI, a company specializing in advanced medical imaging technology, has revealed plans to raise approximately C$13.5 million through a non-brokered private placement 1. This strategic move aims to bolster the company's financial position and accelerate the development and commercialization of its innovative cancer detection technology.

Details of the Private Placement

The private placement will consist of units priced at C$1.40 each. Each unit will comprise one common share of the company and one-half of a common share purchase warrant 2. The full warrants will be exercisable at C$1.90 per share for a period of 24 months following the closing of the offering, subject to certain conditions.

Use of Proceeds

Perimeter Medical Imaging AI intends to utilize the net proceeds from this private placement for several key purposes:

  1. Advancing the development of its artificial intelligence technology
  2. Supporting ongoing clinical studies
  3. Expanding its commercial initiatives
  4. Bolstering working capital and general corporate purposes 1

Market Impact and Investor Interest

The announcement of this private placement has drawn attention from investors and industry observers. The company's focus on AI-powered cancer detection technology positions it at the forefront of medical imaging innovation, potentially addressing critical needs in cancer diagnosis and treatment.

Regulatory Considerations

It's important to note that the private placement is subject to regulatory approvals, including that of the TSX Venture Exchange 2. The company has stated that all securities issued through this offering will be subject to a statutory hold period of four months and one day from the date of issuance.

Company Background

Perimeter Medical Imaging AI specializes in developing advanced in-procedural medical imaging tools aimed at reducing cancer surgery costs and improving patient outcomes. Their flagship product, the S-Series OCT system, provides real-time, cross-sectional visualization of excised tissues at the cellular level, potentially revolutionizing cancer surgery procedures 12.

Future Outlook

This funding initiative underscores Perimeter Medical Imaging AI's commitment to advancing its technology and expanding its market presence. The success of this private placement could significantly impact the company's ability to accelerate its research and development efforts, potentially bringing innovative cancer detection solutions to market faster.

Continue Reading
HEALWELL AI Acquires Orion Health, Forming Global Leader in

HEALWELL AI Acquires Orion Health, Forming Global Leader in Healthcare Data Interoperability and AI

HEALWELL AI Inc. announces acquisition of Orion Health, creating a powerhouse in healthcare technology and AI. The deal, valued at CAD 165 million, aims to revolutionize healthcare through data-driven innovation and AI integration.

Benzinga logoInvesting.com UK logoScoop logoTelecomTalk logo

5 Sources

Benzinga logoInvesting.com UK logoScoop logoTelecomTalk logo

5 Sources

ImmunoPrecise Secures $30 Million Financing Agreement with

ImmunoPrecise Secures $30 Million Financing Agreement with Yorkville Advisors Global LP

ImmunoPrecise Antibodies Ltd. has entered into a financing agreement with Yorkville Advisors Global LP for up to $30 million in convertible debentures. This move aims to strengthen the company's financial position and support its growth initiatives.

Investing.com UK logoMarket Screener logo

2 Sources

Investing.com UK logoMarket Screener logo

2 Sources

AI and Healthcare: Roche, Avant Technologies, and Ainnova

AI and Healthcare: Roche, Avant Technologies, and Ainnova Partner to Combat Diabetic Retinopathy

A strategic alliance between Roche, Avant Technologies' partner Ainnova, and Salud 360 launches a pilot program in Costa Rica using AI to detect diabetic retinopathy, potentially revolutionizing early disease detection in healthcare.

Benzinga logoInvesting.com UK logo

2 Sources

Benzinga logoInvesting.com UK logo

2 Sources

Intermap Technologies Completes Final Tranche of Private

Intermap Technologies Completes Final Tranche of Private Placement

Intermap Technologies Corporation, a global leader in 3D geospatial data and intelligence solutions, has successfully closed the final tranche of its previously announced non-brokered private placement. The company raised additional funds to support its growth initiatives and strengthen its financial position.

Market Screener logoBenzinga logo

2 Sources

Market Screener logoBenzinga logo

2 Sources

Q2 2024 Financial Results: A Mixed Bag for Tech and

Q2 2024 Financial Results: A Mixed Bag for Tech and Healthcare Companies

Several companies, including iCAD, SKYX, Acrivon Therapeutics, and Janover, have reported their second quarter 2024 financial results. While some companies showed growth, others faced challenges in revenue and net losses.

Investing.com UK logoBenzinga logo

6 Sources

Investing.com UK logoBenzinga logo

6 Sources

TheOutpost.ai

Your one-stop AI hub

The Outpost is a comprehensive collection of curated artificial intelligence software tools that cater to the needs of small business owners, bloggers, artists, musicians, entrepreneurs, marketers, writers, and researchers.

© 2025 TheOutpost.AI All rights reserved